Skip to main content
Log in

Evidence favours regular β2-agonist use

  • Newsletter Article
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Evidence favours regular β2-agonist use. Inpharma Wkly. 984, 20 (1995). https://doi.org/10.2165/00128413-199509840-00041

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199509840-00041

Keywords

Navigation